Literature DB >> 30123575

Biomaterials and heart recovery: cardiac repair, regeneration and healing in the MCS era: a state of the "heart".

Sveva Di Franco1, Cristiano Amarelli2, Andrea Montalto3, Antonio Loforte4, Francesco Musumeci3.   

Abstract

Regenerative medicine is an emerging interdisciplinary field of scientific research that, supported by tissue engineering is, nowadays, a valuable and reliable solution dealing with the actual organs shortage and the unresolved limits of biological or prosthetic materials used in repair and replacement of diseased or damaged human tissues and organs. Due to the improvements in design and materials, and to the changing of clinical features of patients treated for valvular heart disease the distance between the ideal valve and the available prostheses has been shortened. We will then deal with the developing of new tools aiming at replacing or repair cardiac tissues that still represent an unmet clinical need for the surgeons and indeed for their patients. In the effort of improving treatment for the cardiovascular disease (CVD), scientists struggle with the lack of self-regenerative capacities of finally differentiated cardiovascular tissues. In this context, using several converging technological approaches, regenerative medicine moves beyond traditional transplantation and replacement therapies and can restore tissue impaired function. It may also play an essential role in surgery daily routine, leading to produce devices such as injectable hydrogels, cardiac patches, bioresorbable stents and vascular grafts made by increasingly sophisticated biomaterial scaffolds; tailored devices promptly fabricated according to surgeon necessity and patient anatomy and pathology will hopefully represent a daily activity in the next future. The employment of these devices, still far from the in vitro reproduction of functional organs, has the main aim to achieve a self-renewal process in damaged tissues simulating endogenous resident cell populations. In this field, the collaboration and cooperation between cardiothoracic surgeons and bioengineers appear necessary to modify these innovative devices employed in preclinical studies according to the surgeon's needs.

Entities:  

Keywords:  Cardiac regeneration; biomaterials; heart failure (HF); mechanical circulatory support (MCS); regenerative medicine

Year:  2018        PMID: 30123575      PMCID: PMC6081365          DOI: 10.21037/jtd.2018.01.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  87 in total

1.  The effect of matrix stiffness of injectable hydrogels on the preservation of cardiac function after a heart attack.

Authors:  Marian Plotkin; Srirangam Ramanujam Vaibavi; Abdul Jalil Rufaihah; Venkateswaran Nithya; Jing Wang; Yonatan Shachaf; Theo Kofidis; Dror Seliktar
Journal:  Biomaterials       Date:  2013-11-21       Impact factor: 12.479

2.  Tissue-engineered vascular grafts: does cell seeding matter?

Authors:  Tamar L Mirensky; Narutoshi Hibino; Rajendra F Sawh-Martinez; Tai Yi; Gustavo Villalona; Toshiharu Shinoka; Christopher K Breuer
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

3.  Partial left ventriculectomy to treat end-stage heart disease.

Authors:  R J Batista; J Verde; P Nery; L Bocchino; N Takeshita; J N Bhayana; J Bergsland; S Graham; J P Houck; T A Salerno
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

4.  Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.

Authors:  Jennifer M Singelyn; Priya Sundaramurthy; Todd D Johnson; Pamela J Schup-Magoffin; Diane P Hu; Denver M Faulk; Jean Wang; Kristine M Mayle; Kendra Bartels; Michael Salvatore; Adam M Kinsey; Anthony N Demaria; Nabil Dib; Karen L Christman
Journal:  J Am Coll Cardiol       Date:  2012-02-21       Impact factor: 24.094

5.  Tissue-engineered vascular grafts created from human induced pluripotent stem cells.

Authors:  Sumati Sundaram; Jennifer One; Joshua Siewert; Stephan Teodosescu; Liping Zhao; Sashka Dimitrievska; Hong Qian; Angela H Huang; Laura Niklason
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

6.  Experimental and clinical studies with the Paracor cardiac restraint device.

Authors:  James A Magovern
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

7.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

8.  In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model.

Authors:  Alejandro Nieponice; Lorenzo Soletti; Jianjun Guan; Yi Hong; Burhan Gharaibeh; Timothy M Maul; Johnny Huard; William R Wagner; David A Vorp
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

9.  Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars.

Authors:  V Dor; M Sabatier; M Di Donato; F Montiglio; A Toso; M Maioli
Journal:  J Thorac Cardiovasc Surg       Date:  1998-07       Impact factor: 5.209

10.  Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering.

Authors:  Hadi Hajiali; Shapour Shahgasempour; M Reza Naimi-Jamal; Habibullah Peirovi
Journal:  Int J Nanomedicine       Date:  2011-09-27
View more
  2 in total

Review 1.  Engineered biomaterials for heart disease.

Authors:  Lyndsay Stapleton; Yuanjia Zhu; Yi-Ping Joseph Woo; Eric Appel
Journal:  Curr Opin Biotechnol       Date:  2020-10-01       Impact factor: 9.740

Review 2.  Antimicrobial Properties of Extracellular Matrix Scaffolds for Tissue Engineering.

Authors:  Germán R Jiménez-Gastélum; Elsa M Aguilar-Medina; Eduardo Soto-Sainz; Rosalío Ramos-Payán; Erika L Silva-Benítez
Journal:  Biomed Res Int       Date:  2019-12-13       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.